Natural Compound from Olive Oil Inhibits S100A9 Amyloid Formation and Cytotoxicity: Implications for Preventing Alzheimer’s Disease

Polyphenolic compounds in the Mediterranean diet have received increasing attention due to their protective properties in amyloid neurodegenerative and many other diseases. Here, we have demonstrated for the first time that polyphenol oleuropein aglycone (OleA), which is the most abundant compound in olive oil, has multiple potencies for the inhibition of amyloid self-assembly of pro-inflammatory protein S100A9 and the mitigation of the damaging effect of its amyloids on neuroblastoma SH-SY5Y cells. OleA directly interacts with both native and fibrillar S100A9 as shown by intrinsic fluorescence and molecular dynamic simulation. OleA prevents S100A9 amyloid oligomerization as shown using amyloid oligomer-specific antibodies and cross-β-sheet formation detected by circular dichroism. It decreases the length of amyloid fibrils measured by atomic force microscopy (AFM) as well as reduces the effective rate of amyloid growth and the overall amyloid load as derived from the kinetic analysis of amyloid formation. OleA disintegrates already preformed fibrils of S100A9, converting them into nonfibrillar and nontoxic aggregates as revealed by amyloid thioflavin-T dye binding, AFM, and cytotoxicity assays. At the cellular level, OleA targets S100A9 amyloids already at the membranes as shown by immunofluorescence and fluorescence resonance energy transfer, significantly reducing the amyloid accumulation in GM1 ganglioside containing membrane rafts. OleA increases overall cell viability when neuroblastoma cells are subjected to the amyloid load and alleviates amyloid-induced intracellular rise of reactive oxidative species and free Ca2+. Since S100A9 is both a pro-inflammatory and amyloidogenic protein, OleA may effectively mitigate the pathological consequences of the S100A9-dependent amyloid-neuroinflammatory cascade as well as provide protection from neurodegeneration, if used within the Mediterranean diet as a potential preventive measure.

[1]  R. Antoine,et al.  Templating S100A9 amyloids on Aβ fibrillar surfaces revealed by charge detection mass spectrometry, microscopy, kinetic and microfluidic analyses , 2020, bioRxiv.

[2]  M. Bucciantini,et al.  Healthy Effects of Plant Polyphenols: Molecular Mechanisms , 2020, International journal of molecular sciences.

[3]  S. Tomasi,et al.  UV-Vis Spectroelectrochemistry of Oleuropein, Tyrosol, and p-Coumaric Acid Individually and in an Equimolar Combination. Differences in LC-ESI-MS2 Profiles of Oxidation Products and Their Neuroprotective Properties , 2019, Biomolecules.

[4]  M. Bucciantini,et al.  Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol. , 2019, Biochemical pharmacology.

[5]  A. Gräslund,et al.  Pro-Inflammatory S100A9 Protein Aggregation Promoted by NCAM1 Peptide Constructs. , 2019, ACS chemical biology.

[6]  N. Marklund,et al.  Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model , 2019, Neuroscience Letters.

[7]  M. Bucciantini,et al.  Oleuropein aglycone and hydroxytyrosol interfere differently with toxic Aβ1-42 aggregation. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  Sunhwan Jo,et al.  CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. , 2018, Journal of chemical theory and computation.

[9]  S. Shankar,et al.  S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer’s Disease , 2018, Scientific Reports.

[10]  I. Horváth,et al.  Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson’s disease: ex vivo and in vitro studies , 2018, Journal of Neuroinflammation.

[11]  M. Bucciantini,et al.  Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity. , 2018, Biochimica et biophysica acta. General subjects.

[12]  M. Bucciantini,et al.  Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates , 2018, Scientific Reports.

[13]  D. Raleigh,et al.  RAGE binds preamyloid IAPP intermediates and mediates pancreatic &bgr; cell proteotoxicity , 2018, The Journal of clinical investigation.

[14]  V. Smirnovas,et al.  Finke-Watzky Two-Step Nucleation-Autocatalysis Model of S100A9 Amyloid Formation: Protein Misfolding as "Nucleation" Event. , 2017, ACS chemical neuroscience.

[15]  Charles L. Brooks,et al.  CHARMM‐GUI ligand reader and modeler for CHARMM force field generation of small molecules , 2017, J. Comput. Chem..

[16]  Ž. Svedružić,et al.  In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1 , 2017, PloS one.

[17]  Yanbo Zhang,et al.  The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2017, CNS neuroscience & therapeutics.

[18]  S. Strittmatter,et al.  Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease. , 2017, Biochemical and biophysical research communications.

[19]  M. Sperandio,et al.  S100A8/A9: From basic science to clinical application. , 2016, Pharmacology & therapeutics.

[20]  Hongchun Li,et al.  Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation. , 2016, Biochimica et biophysica acta.

[21]  S. Strittmatter,et al.  Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease* , 2016, The Journal of Biological Chemistry.

[22]  Seung-Jae Lee,et al.  Neuroinflammation in Synucleinopathies , 2016, Brain pathology.

[23]  S. Doglia,et al.  The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. , 2016, The Journal of nutritional biochemistry.

[24]  M. Bucciantini,et al.  Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin , 2016, Journal of cellular and molecular medicine.

[25]  H. Zetterberg,et al.  Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease. , 2016, ACS chemical neuroscience.

[26]  M. Stefani,et al.  Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight , 2015, Oncotarget.

[27]  M. Stefani,et al.  Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation , 2014, BioFactors.

[28]  C. Bremer,et al.  Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity , 2014, Nature Communications.

[29]  Xavier Barril,et al.  rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids , 2014, PLoS Comput. Biol..

[30]  Franco Quercioli,et al.  A molecular imaging analysis of C×43 association with Cdo during skeletal myoblast differentiation , 2014, Photonics West - Biomedical Optics.

[31]  Patrick Walsh,et al.  The Mechanism of Membrane Disruption by Cytotoxic Amyloid Oligomers Formed by Prion Protein(106–126) Is Dependent on Bilayer Composition* , 2014, The Journal of Biological Chemistry.

[32]  S. Shankar,et al.  The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade , 2013, Acta Neuropathologica.

[33]  M. Stefani,et al.  The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology , 2013, PloS one.

[34]  L. Formigli,et al.  A molecular imaging analysis of Cx43 association with Cdo during skeletal myoblast differentiation , 2013, Journal of biophotonics.

[35]  A. Tall,et al.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. , 2013, Cell metabolism.

[36]  Francesco S Pavone,et al.  Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates , 2013, FEBS letters.

[37]  L. Morozova-Roche,et al.  Aggregation of Human S100A8 and S100A9 Amyloidogenic Proteins Perturbs Proteostasis in a Yeast Model , 2013, PloS one.

[38]  J. Voorhees,et al.  Robust shifts in S100a9 expression with aging: A novel mechanism for chronic inflammation , 2013, Scientific Reports.

[39]  Wim F Vranken,et al.  ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.

[40]  R. Veerhuis,et al.  Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease , 2012, Alzheimer's Research & Therapy.

[41]  M. Fujita,et al.  S100A8/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure. , 2012, International journal of cardiology.

[42]  Francesco Pavone,et al.  Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  M. Bucciantini,et al.  Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. , 2011, Current Alzheimer research.

[44]  G. Lippens,et al.  Oleuropein and derivatives from olives as Tau aggregation inhibitors , 2011, Neurochemistry International.

[45]  J. Marsh,et al.  Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers , 2010, Molecular Neurodegeneration.

[46]  M. Bucciantini,et al.  Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. , 2010, The Journal of nutritional biochemistry.

[47]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[48]  C. Dobson,et al.  Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate , 2009, PloS one.

[49]  R. Keast,et al.  Chemistry and Health of Olive Oil Phenolics , 2008, Critical reviews in food science and nutrition.

[50]  A. Gliozzi,et al.  Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells* , 2008, Journal of Biological Chemistry.

[51]  T. Vogl,et al.  Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. , 2006, Biochimica et biophysica acta.

[52]  O. Bocharova,et al.  Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons* , 2006, Journal of Biological Chemistry.

[53]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[54]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[55]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[56]  Fabrizio Chiti,et al.  Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.

[57]  B. Sacchetti,et al.  Astrocyte modulation of in vitro β‐amyloid neurotoxicity , 2004, Glia.

[58]  P. Eilers A perfect smoother. , 2003, Analytical chemistry.

[59]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[60]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[61]  P. Kremsner,et al.  Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells , 1998, Acta Neuropathologica.

[62]  H. Schluesener,et al.  Expression of the S‐100 proteins MRP‐8 and ‐14 in ischemic brain lesions , 1997, Glia.

[63]  Z. Wasylewski,et al.  Fluorescence-quenching-resolved spectroscopy of proteins. , 1988, European journal of biochemistry.

[64]  A. Diaspro,et al.  Amyloid and membrane complexity: The toxic interplay revealed by AFM. , 2018, Seminars in cell & developmental biology.

[65]  M. Stefani,et al.  The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study. , 2016, Journal of Alzheimer's disease : JAD.

[66]  J. Markowitz,et al.  Review of S100A9 biology and its role in cancer. , 2013, Biochimica et biophysica acta.

[67]  K. Yanagisawa [Amyloid hypothesis]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[68]  Kwok-Fai So,et al.  Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. , 2009, Neurotoxicology.

[69]  I. Ferrer,et al.  Prion protein expression in senile plaques in Alzheimer's disease , 2000, Acta Neuropathologica.

[70]  R. Wetzel,et al.  Amyloid, prions, and other protein aggregates , 1999 .

[71]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[72]  H. Levine Thioflavine T interaction with amyloid β-sheet structures , 1995 .